基本信息
浏览量:6
职业迁徙
个人简介
Professor Radford has had a career long interest in Hodgkin and non-Hodgkin lymphoma. He has undertaken internationally leading research in the field most notably with respect to developing the evidence base for PET scan directed therapy in Hodgkin lymphoma. He took a leading role in the clinical development of brentuximab vedotin. He has a long association with the UK NCRI Lymphoma Clinical Studies Group and was chair from 2011-2017. He currently leads the NIHR Manchester Patient Safety Translational Research Centre’s theme on the oncology tertiary care/primary care interface.
He has a major interest in reducing late treatment toxicity especially in second cancers and in collaboration with Public Health England has led the development of a national database (BARD) of women at high risk of breast cancer following radiotherapy for lymphoma patients under the age of 36. He chairs the Centre for Living Beyond Cancer Science steering committee and is also leading several digital health projects. One of these, RAPID-digital, was recently designated a national exemplar by Health Data Research UK. He has published more than 400 academic papers, been cited in excess of 20,000 times, generated £13m in research funding over the last 5 years and given numerous invited talks most recently in the US and Europe.
He has a major interest in reducing late treatment toxicity especially in second cancers and in collaboration with Public Health England has led the development of a national database (BARD) of women at high risk of breast cancer following radiotherapy for lymphoma patients under the age of 36. He chairs the Centre for Living Beyond Cancer Science steering committee and is also leading several digital health projects. One of these, RAPID-digital, was recently designated a national exemplar by Health Data Research UK. He has published more than 400 academic papers, been cited in excess of 20,000 times, generated £13m in research funding over the last 5 years and given numerous invited talks most recently in the US and Europe.
研究兴趣
论文共 564 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF CLINICAL ONCOLOGYno. 1 (2024): 13-+
Juan Pablo Alderuccio,Isildinha M Reis,Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom,Brad S Kahl,Weiyun Z Ai,John Radford,Melhem Solh,Kirit M Ardeshna,Brian T Hess,Matthew A Lunning,
Clinical cancer research : an official journal of the American Association for Cancer Researchno. 1 (2024): 139-149
Haematologicano. 4 (2024): 1184-1193
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2302763-JCO2302763, (2024)
Mehdi Hamadani, Alexander Spira,Xiaolei Zhou,Laura Liao,Lei Chen,John Radford, Weiyun Ai,Melhem Solh,Kirit M. Ardeshna,Brian Hess,Paolo F. Caimi,Anastasios Stathis,
BLOOD ADVANCESno. 1 (2024): 93-98
HemaSphereno. S3 (2023): e5749555-e5749555
引用0浏览0引用
0
0
Ann Tivey,Rohan Shotton,Sally Taylor, Rachel Oakley,Sara Summerton,Prerana Huddar, Michael King,Jane Gibson,Charlotte Eastwood,Tim Cooksley,David C. Wong,John Radford
Research Square (Research Square) (2023)
Blood (2023): 3058
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn